R Vassallo, JH Ryu - Clinics in chest medicine, 2004 - Elsevier Pulmonary Langerhans' cell histiocytosis (PLCH) is an uncommon but important cause of interstitial
lung disease, and it occurs predominantly in adult cigarette smokers [1]. PLCH belongs to the
spectrum of Langerhans' cell histiocytosis (LCH), diseases characterized by uncontrolled ... Cited by 301 - Related articles - BL Direct - All 14 versions
C VEYSSIER-BELOT, P CACOUB, D CAPARROS- … - Medicine, 1996 - journals.lww.com From Service de medecine interne (CVB, PC, B Wechsler, PG), and Service d'endocrinologie
(AG), hopital Pitie-Salpetriere, Paris; Service de neurologie (DCL, HP), hopital B and Service
de radiologie (MR), hopital Calmette, CHRU Lille; and Clinique des maladies ... Cited by 213 - Related articles - BL Direct - All 3 versions
V Broadbent, H Gadner - Hematology/oncology clinics of North America, 1998 - Elsevier Treatment of Langerhans cell histiocytosis (LCH) over the past 50 years has reflected the changing
concepts of the disease process. Fifty years ago the disease was thought to be of infective origin
and was treated with antibiotics. 1 During the 1960s and 1970s it was thought to be a ... Cited by 99 - Related articles - BL Direct - All 4 versions
I Baumgartner, MD Arthur von Hochstetter, B … - Pediatric Blood & … - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 69 - Related articles - BL Direct - All 3 versions
- ►hematologylibrary.org A Saven, C Burian - Blood, 1999 - bloodjournal.hematologylibrary.org Langerhans-cell histiocytosis (LCH) results from the accumulation of tissue histiocytes derived
from the same progenitor cells as monocytes. Because cladribine is potently toxic to
monocytes, we conducted a phase II trial of cladribine. Cladribine was administered to 13 ... Cited by 56 - Related articles - BL Direct - All 6 versions
A Tefferi, MN Silverstein, CY Li - British journal of haematology, 1997 - interscience.wiley.com 2-Chlorodeoxyadenosine (2-CdA) is a purine nucleoside analogue with therapeutic activity in
low-grade lymphoproliferative disorders. In addition, 2-CdA has a potent myelosuppressive
effect, and it has been shown to be toxic to malignant myeloid cells both in vitro and in ... Cited by 47 - Related articles - BL Direct - All 3 versions
- ►oxfordjournals.org [PDF] G Juliusson, J Liliemark - Annals of Oncology, 1996 - Eur Soc Med Oncology Page 1. Annals of Oncology 7: 373-379, 1996. O 1996 Kluwer Academic Publishers. Printed
in the Netherlands. Original article Long-term survival following cladribine (2-
chlorodeoxyadenosine) therapy in previously treated patients with chronic lymphocytic leukemia ... Cited by 44 - Related articles - BL Direct - All 3 versions
S Weitzman, AS Wayne, R Arceci, JM … - Medical and …, 1999 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 41 - Related articles - BL Direct - All 3 versions
A Pardanani, RL Phyliky, CY Li, A … - Mayo Clinic …, 2003 - mayoclinicproceedings.com From the Division of Hematology and Internal Medicine (AP, RLP, AT) and Division of Hematopathology
(C.-YL), Mayo Clinic, Roch- ester, Minn. Address reprint requests and correspondence to Ayalew
Tefferi, MD, Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN 55905 ... Cited by 37 - Related articles - View as HTML - BL Direct - All 9 versions
- ►aacrjournals.org [PDF] F Albertioni, S Lindemalm, V Reichelova, B Pettersson … - Clinical Cancer Research, 1998 - AACR Pharmacokinetics of Cladribine in Plasma and Its ... Freidoun Albertioni,2 Synn#{246}ve
Lindemalm, Viera Reichelova, Birgitta Pettersson, Staffan Eriksson, Gunnar Juliusson, and Jan
Liliemark Departments of Clinical Pharmacology [FA, SL, VR, BP1 and Oncology [J. LI, ... Cited by 31 - Related articles - BL Direct - All 6 versions
